Kures

Kures is a pre-clinical-stage biopharmaceutical startup company that develops opioid-based treatments for depressive disorder.

The company targets the significant intersection between pain and opioid use disorder, its product is under evaluation for treating subsets of depression through a mechanism of action, offering medical practitioners a potentially safer and widely available alternative for pain management and opioid maintenance therapy.

The company has interest in addressing other challenging indications in the psychiatry and physical pain arena using its portfolio of novel small molecules. It currently operates in Stealth mode.